Biogen Message Board - Msg: 4010197

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 168.83

+2.4%

Nov 18 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harold Engstrom who wrote (632)	4/9/1998 12:22:00 AM
From: Vector1	Read Replies (1) of 1686

Harold, thanks for the excellent summary. Looked like Avonex sales continued to be robust. Was there any discussion of Avonex's growth in Europe. Also royalties were down about $4m year over year for the quarter. Last year they were still signaling double digit growth and Intron A has been strong. I am looking forward to reading the transcript and we will see what the street thinks of the numbers tomorrow. V1

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next